Genprex, Inc.
GNPX
$0.67
-$0.01-0.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -24.98% | -38.08% | -52.06% | -54.79% | -29.98% |
| Depreciation & Amortization | -- | -- | -94.85% | -85.12% | -69.85% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.56% | -23.84% | -31.90% | -37.16% | -33.99% |
| Operating Income | 12.56% | 23.84% | 31.90% | 37.16% | 33.99% |
| Income Before Tax | 12.45% | 23.12% | 26.17% | 33.89% | 30.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.46% | 23.13% | 26.16% | 33.88% | 30.84% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.46% | 23.13% | 26.16% | 33.88% | 30.84% |
| EBIT | 12.56% | 23.84% | 31.90% | 37.16% | 33.99% |
| EBITDA | 37.06% | 23.84% | 31.90% | 37.15% | 33.98% |
| EPS Basic | 93.63% | 93.43% | 91.52% | 86.69% | 74.19% |
| Normalized Basic EPS | 93.51% | 93.22% | 92.17% | 87.12% | 74.44% |
| EPS Diluted | 93.63% | 93.43% | 91.52% | 86.69% | 74.19% |
| Normalized Diluted EPS | 93.51% | 93.22% | 92.17% | 87.12% | 74.44% |
| Average Basic Shares Outstanding | 1,648.88% | 1,063.62% | 922.42% | 721.01% | 406.92% |
| Average Diluted Shares Outstanding | 1,648.88% | 1,063.62% | 922.42% | 721.01% | 406.92% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |